Clinical trial
Role of Epidermal Growth Factor (EGF) in Development of Necrotizing…
NCT00059449 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00059449 |
|---|---|
| Title | Role of Epidermal Growth Factor (EGF) in Development of Necrotizing Enterocolitis |
| Official title | Role of Epidermal Growth Factor (EGF) in Development of Necrotizing Enterocolitis |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Necrotizing Enterocolitis, Premature Birth |
| Enrollment | 372 |
| First posted | Apr 29, 2003 |
| Last update posted | Jan 13, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: